You are here: Industry Insights > Microbiome

News List

Live Biotherapeutics: Targeting The Microbiome For The Cancer Treatment Shruti Talashi
March 18, 2024
The quest to create microbial products that can influence cancer outcomes has been rekindled by the mounting evidence of the role that microbiota plays in human health and illness.
The Rise of the Microbiome Revolution: Micro-biome therapeutics (MT) in health sector Shruti Talashi
March 08, 2024
To gain a better knowledge of the micro-biome's role in health and disease, the human microbiome project was started in 2007.
Gut Feeling about Drugs: How the Microbiome Shapes Drug Response Shruti Talashi
February 05, 2024
About 10-100 trillion symbiotic microbial cells are carried by each individual, mostly in the gut, that are known as the human microbiota.
G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI prnasia
February 15, 2022
IMI - Integrated Medicine Institute, Asia's largest natural health clinic, is pleased to announce the availability of G-NiiB Immunity Pro and G-NiiB Immunity Plus probiotic formulas designed to tackle gut bacterial imbalances...
Eagle Genomics and Quadram Institute’s New Strategic Partnership to Accelerate Microbiome Analysis Through AI-Augmented Knowledge Discovery Platform B3Cnewswire
January 14, 2022
Today, Eagle Genomics, the Deep Tech software business pioneering the application of network science to biology, and the Quadram Institute, a world-leading institute creating new interfaces between food science...
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism prnasia
August 05, 2021
The Faculty of Medicine of The Chinese University of Hong Kong, S.A.R., China (CU Medicine) reports a ground breaking discovery that children with autism spectrum disorder (autism) showed delayed gut microbiome maturity compared with typically developing
Microbiome-targeting treatment is set to evolve, address multiple immunological indications: GlobalData expresspharma
July 12, 2021
Microbiome is a space with high potential, a fact underlined by the complete absence of microbiome-targeting treatments on the market.
Global Microbiome Markets Report 2021: Market is Expected to Reach $15.55 Billion in 2030, at a CAGR of 11.4% prnewswire
July 08, 2021
The "Microbiome Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
Seres and Nestlé enter up to $525m deal for microbiome therapeutic pharmaceutical-technology
July 05, 2021
Seres Therapeutics has signed an agreement with Nestlé Health Science to co-market the former’s investigational treatment, SER-109, for recurrent Clostridioides difficile infection (CDI) in the US and Canada.
C-Section Babies Miss Out on Mom's 'Microbiome,' But Treatment Can Change That drugs
June 24, 2021
When a baby is born, the mother's body provides a pathway into the world, but the journey also exposes them to beneficial bacteria that live in and on their mom. But that critical exchange doesn't happen during a cesarean section delivery.